Obstetrics/Gynecology
RSSArticles
-
Contraceptive Technology Update June 2009 Issue in PDF
-
STD Quarterly: Boost efforts to close STD prevention gaps
Sexually transmitted diseases (STDs) remain a major U.S. public health challenge. About 19 million new infections occur each year, with almost half of them among young people ages 15 to 24.1 What are you doing to close the gaps when it comes to STD prevention in this age group? -
STD Quarterly: Research update: Male circumcision reduces risk of genital herpes and HPV infection
Findings from two parallel clinical trials in Rakai, Uganda, indicate that heterosexual men who undergo medical circumcision can significantly reduce their risk of acquiring two common sexually transmitted diseases (STDs): herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV). -
OB/GYN Clinical Alert June 2009 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Guidance on the Appropriate Use of NSAIDs
n this issue: NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions. -
Special Feature: Swing and Miss?!? Efforts in Front-line Ovarian Cancer Chemotherapy Development
Data from the Surveillance Epidemiology and End Results (SEER) registry have consistently demonstrated improved life expectancy for women with epithelial ovarian cancer every year since 1973. -
Prognosis for Spontaneous Labor in Women with Uncomplicated Term Pregnancies
During the last two months an unusual number of papers were published which, while not having earth-shaking scientific value, should have some clinical impact. -
Fertility Following Oral Contraceptives
A review of any publication from 1960 to 2007 with the main outcome of time to fertility following oral contraceptive discontinuation was performed. -
Arzoxifene for Prevention of Osteoporosis
Arzoxifene is being developed by Eli Lilly and Co. to prevent bone loss and treat osteoporosis.